OCT can characterize corneoscleral junction

Article

Optical coherence tomography (OCT) can be used to characterize the angle and topography of the corneoscleral junction, according to newly published research.

Optical coherence tomography (OCT) can be used to characterize the angle and topography of the corneoscleral junction, according to research published in Optometry and Vision Science.

The novel, quantitative method used by the researchers also established differences among quadrants of the ocular surface, and between ethnic groups.

The researchers recruited a total of 48 subjects (16 Asian, 16 White and 16 Latino), and took OCT images in both eyes of the subjects' nasal, temporal, superior and inferior quadrants. Custom image analysis software allowed selection of a point defining the centre of the corneoscleral junction, and 20 concentric circles were drawn from this point. Edge-detection routines located the surface of the junction, and a linear regression was fit to the series of points that defined the circles intersecting this edge. A set of metrics was then calculated based on the regression residuals.

The researchers found that the most repeatable metric was the sum of the squared orthogonalized residuals (SSRo). In addition, this metric was unaffected by the orientation of the image.

The SSRo was greatest (indicating a more pronounced angle and/or rougher surface) in the nasal quadrant (p p

To read an abstract of the study, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.